Akero Therapeutics
AKRO
AKRO
97 hedge funds and large institutions have $700M invested in Akero Therapeutics in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 43 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
99% less call options, than puts
Call options by funds: $44K | Put options by funds: $4.01M
Holders
97
Holding in Top 10
2
Calls
$44K
Puts
$4.01M
Top Buyers
| 1 | +$30.5M | |
| 2 | +$17M | |
| 3 | +$9.5M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$7.22M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.17M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$6.04M | |
| 3 | -$4.49M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.67M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.54M |